USPTO serial 90980299
AINOVO
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Sep 26, 2023
- Examiner
- TENG, SIMON
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with AINOVO?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Lynn M. Humphreys
Lynn M. Humphreys HOPKINS & CARLEY70 S 1ST STSAN JOSE, CA 95113UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 042 | Biotechnology research; Computer software development in the field of artificial intelligence, biotechnology, pharmaceuticals, and medical applications; Laboratory research services relating to pharmaceuticals; Medical and scientific research in the field of cancer treatment and diagnosis; Providing information on the subject of scientific research in the field of biochemistry and biotechnology; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Providing on-line non-downloadable software using artificial intelligence for use in facilitating product development in the field of biotechnology, pharmaceuticals, and medicine; Research and development in the pharmaceutical and biotechnology fields; Scientific research for medical purposes in the area of cancerous diseases; Software as a service (SAAS) services featuring software using artificial intelligence for use in facilitating product development in the field of biotechnology, pharmaceuticals, and medicine; Technical consulting in the field of pharmaceutical studies; Technology consultation in the field of artificial intelligence; Testing of pharmaceuticals; Testing, inspection or research of pharmaceuticals, cosmetics or foodstuff; Computer software consulting | ACTIVE | Apr 23, 2020 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 26, 2023 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Sep 26, 2023 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Aug 22, 2023 | SUNA | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | — |
| Aug 19, 2023 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| Aug 11, 2023 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Aug 11, 2023 | DPCC | DIVISIONAL PROCESSING COMPLETE | — |
| Aug 11, 2023 | CORV | REVIEW OF CORRESPONDENCE COMPLETE | — |
| Aug 9, 2023 | IROA | RESPONSE TO ITU OFFICE ACTION ENTERED | — |
| Aug 9, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 9, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 10, 2023 | INCD | ITU OFFICE ACTION ISSUED FOR DIVISIONAL REQUEST | — |
| Jul 3, 2023 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Jun 13, 2023 | IUAF | USE AMENDMENT FILED | — |
| Jun 13, 2023 | DRRR | DIVISIONAL REQUEST RECEIVED | — |
| Jun 13, 2023 | ERTD | TEAS REQUEST TO DIVIDE RECEIVED | — |
| Jun 13, 2023 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| Jun 13, 2023 | ERTD | TEAS REQUEST TO DIVIDE RECEIVED | — |
| Dec 2, 2022 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Nov 30, 2022 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Nov 30, 2022 | EXT1 | SOU EXTENSION 1 FILED | — |
| Nov 30, 2022 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jun 14, 2022 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Apr 19, 2022 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Apr 19, 2022 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 30, 2022 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Mar 16, 2022 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 16, 2022 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Mar 16, 2022 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Mar 16, 2022 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Mar 16, 2022 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Feb 14, 2022 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 14, 2022 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 13, 2022 | ALIE | ASSIGNED TO LIE | — |
| Feb 9, 2022 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 9, 2021 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 9, 2021 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 9, 2021 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 3, 2021 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 21, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jan 23, 2021 | NWAP | NEW APPLICATION ENTERED | — |